60
Participants
Start Date
August 5, 2025
Primary Completion Date
October 25, 2026
Study Completion Date
October 25, 2026
Placebo
Oral tablet
PF-07258669
Oral tablet
NOT_YET_RECRUITING
Headlands Research Orlando, Orlando
RECRUITING
De La Cruz Research Center, LLC, Miami
NOT_YET_RECRUITING
JEM Research Institute, Atlantis
NOT_YET_RECRUITING
AA Medical Research Center, Flint
RECRUITING
Clinical Research Professionals, Chesterfield
NOT_YET_RECRUITING
Javara - Nevada Health Centers - Carson City, Carson City
NOT_YET_RECRUITING
Shields MRI Brockton, Brockton
NOT_YET_RECRUITING
Headlands Eastern MA LLC, Plymouth
NOT_YET_RECRUITING
Circuit Clinical, Secaucus
NOT_YET_RECRUITING
Circuit Clinical /North Hudson Community Action Corporation, New York
NOT_YET_RECRUITING
Alpha Recherche Clinique - Lévis, Lévis
NOT_YET_RECRUITING
Diex Recherche Trois-Rivieres, Trois-Rivières
Lead Sponsor
Pfizer
INDUSTRY